Login / Signup

An ex vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex.

P PekingJ S BreitenbachM AblingerW H MussF J PoetschkeT KocherU KollerS HainzlS KitzmuellerJ W BauerJulia ReicheltT LettnerVerena Wally
Published in: The British journal of dermatology (2018)
Our data demonstrate that trans-splicing-mediated mRNA therapy is an effective method for the correction of dominantly inherited KRT14 mutations at the transcriptional level. This results in the rescue of the EBS-gen sev phenotype and stabilization of the epidermis in a xenograft mouse model.
Keyphrases
  • mouse model
  • endothelial cells
  • induced pluripotent stem cells
  • electronic health record
  • gene expression
  • early onset
  • big data
  • pluripotent stem cells
  • binding protein
  • oxidative stress
  • bone marrow
  • cell therapy